Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on July 30, 2026

4 hours ago

Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June

Indeterminate GlobeNewswire

4 hours ago

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

4 hours ago

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Indeterminate GlobeNewswire

4 hours ago

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

4 hours ago

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

4 hours ago

Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109

Indeterminate GlobeNewswire

4 hours ago

PharmAla Issues Q3 Financial Statements and AGM Update

Indeterminate GlobeNewswire

4 hours ago

InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Indeterminate GlobeNewswire

4 hours ago

Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

Indeterminate GlobeNewswire

4 hours ago

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

5 hours ago

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

Indeterminate GlobeNewswire

5 hours ago

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

Indeterminate GlobeNewswire

5 hours ago

Atavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

5 hours ago

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

5 hours ago

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

5 hours ago

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Indeterminate GlobeNewswire

5 hours ago

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

5 hours ago

HUTCHMED Reports 2026 Interim Results

Indeterminate GlobeNewswire

5 hours ago

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire